Macpril 5 Tablet contains Ramipril 5 mg, an angiotensin-converting enzyme (ACE) inhibitor primarily indicated for the management of hypertension and heart failure. By inhibiting the ACE enzyme, Ramipril reduces the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and lowering blood pressure. This mechanism also decreases aldosterone secretion, resulting in reduced sodium and water retention, which helps alleviate cardiac workload. Macpril 5 is commonly prescribed to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients with established cardiovascular disease or diabetes with additional risk factors. It is also effective in improving survival rates post-myocardial infarction and in managing diabetic nephropathy by slowing the progression of kidney damage. The usual dosage should be individualized based on patient response and clinical condition, with regular monitoring of blood pressure, renal function, and serum electrolytes recommended to detect potential adverse effects such as hyperkalemia, hypotension, or renal impairment. Macpril 5 should be used cautiously in patients with renal artery stenosis, pregnancy, or a history of angioedema. Adherence to prescribed dosing and consultation with healthcare professionals is essential for optimal therapeutic outcomes.